Don't miss our weekly PhD newsletter | Sign up now Don't miss our weekly PhD newsletter | Sign up now

  BBSRC MIBTP - Investigating the role of protein lysine methylation in the DNA damage response.


   Institute of Cancer and Genomic Sciences

This project is no longer listed on FindAPhD.com and may not be available.

Click here to search FindAPhD.com for PhD studentship opportunities
  Dr M Higgs, Dr M Saponaro  No more applications being accepted  Competition Funded PhD Project (European/UK Students Only)

About the Project

Our DNA is under constant attack from DNA damaging agents, which are a continuing threat to genomic integrity. To counteract this, multiple DNA damage response (DDR) proteins have evolved to detect DNA damage, activate cell cycle checkpoints, and promote the repair and resolution of DNA lesions. The activity of these factors is controlled by a complex network of post-translational modifications (PTMs).
My group is interested in one particular DDR-associated PTM, lysine methylation, and the enzymes that catalyse this. These ‘lysine methyltransferases’ play vital roles in normal cellular function and organismal development, during transcription, and in preventing cellular transformation. Our main focus is on how these enzymes control the DDR and help maintain genome stability.
This PhD will specifically investigate how members of the KMT2 family of lysine methyltransferases function in the DDR. The project has three main objectives:
1) Uncover the role that specific methyltransferases play in the DDR: To achieve this objective, cellular sensitivity assays using DNA damage-inducing agents will be carried out in cells depleted of these enzymes by RNAi. In parallel, the levels of genome instability in these cells will be analysed by light microscopy, and the recruitment of known DDR factors to sites of DNA damage will be assessed by immunofluorescence.
2) Examine how lysine methyltransferases regulate known DDR factors through Lys methylation: To assess this, lysine methylated DDR proteins will be isolated using pulldown/immunoprecipitation assays, and the precise site(s) of methylation will be uncovered using mass spectrometry. In vitro activity assays will then be used to determine whether these proteins are directly methylated.
3) Investigate how Lys methylation affects the interplay between transcription stress and DNA damage. To uncover how these KMT2 methyltransferases also regulate transcription after DNA damage, we will perform genome-wide transcriptional profiling of cells lacking specific KMT2 proteins before and after DNA damage, in collaboration with Dr. Marco Saponaro.
Together, these integrated approaches will lead to a greater understanding of how lysine methylation helps to maintain the integrity of the genome.

For further information, please contact [Email Address Removed].

Person Specification:
Applicants should have a strong background in molecular and cellular biology, with experience of one or more of the following laboratory techniques: mammalian tissue culture; immunofluorescence; immunoblotting or molecular cloning. Previous experience of a research lab environment is essential. They should be ambitious, enthusiastic and self-motivated, and should meet the eligibility criteria outlined below.

Funding Notes

This studentship is competition funded by the BBSRC MIBTP scheme: https://www.birmingham.ac.uk/research/activity/mibtp/index.aspx

Deadline: January 8, 2018
Number of Studentships available: 30
Stipend: RCUK standard rate (plus travel allowance in Year 1 and a laptop).

The Midlands Integrative Biosciences Training Partnership (MIBTP) is a BBSRC-funded doctoral training partnership between the universities of Warwick, Birmingham and Leicester. It delivers innovative, world-class research training across the Life Sciences to boost the growing Bioeconomy across the UK.

To check your eligibility to apply for this project please visit: https://www2.warwick.ac.uk/fac/cross_fac/mibtp/pgstudy/phd_opportunities/application/

References

BOD1L is required to suppress deleterious resection of stressed replication forks. Higgs MR et al., 2015, Mol Cell: 59; 462-77.

Hijacked in cancer: the KMT2 (MLL) family of methyltransferases. Rao and Dou, 2015, Nature Reviews Cancer: 15; 334-346.

Quantitative dissection and stoichiometry determination of the human SET1/MLL histone methyltransferase complexes. Van Nuland et al., 2013, Mol Cell Biol: 33; 2067-77.

Mutation of cancer driver MLL2 results in transcription stress and genome instability. Kantidakis et al., 2016; Genes Dev: 15; 408-20.

Where will I study?